Detalhe da pesquisa
1.
Prognostic factors for patients with hematologic malignancies admitted to the intensive care unit: is allogeneic transplantation still a risk factor?
Ann Hematol
; 102(4): 907-916, 2023 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-36757444
2.
Efficacy and safety of letermovir prophylaxis for cytomegalovirus infection after hematopoietic stem cell transplantation.
Blood Sci
; 6(1): e00178, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-38213825
3.
Machine learning algorithm as a prognostic tool for Epstein-Barr virus reactivation after haploidentical hematopoietic stem cell transplantation.
Blood Sci
; 5(1): 51-59, 2023 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-36742189
4.
Efficacy and safety of ruxolitinib in steroid-refractory graft-versus-host disease: A meta-analysis.
Front Immunol
; 13: 954268, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35990629
5.
Efficacy and safety of mesenchymal stem cells treatment for multidrug-resistant graft-versus-host disease after haploidentical allogeneic hematopoietic stem cell transplantation.
Ther Adv Hematol
; 13: 20406207211072838, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35096361
6.
Preemptive Interferon-α Therapy Could Protect Against Relapse and Improve Survival of Acute Myeloid Leukemia Patients After Allogeneic Hematopoietic Stem Cell Transplantation: Long-Term Results of Two Registry Studies.
Front Immunol
; 13: 757002, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35154096
7.
A Predicted Model for Refractory/Recurrent Cytomegalovirus Infection in Acute Leukemia Patients After Haploidentical Hematopoietic Stem Cell Transplantation.
Front Cell Infect Microbiol
; 12: 862526, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35392613
8.
A comprehensive model to predict severe acute graft-versus-host disease in acute leukemia patients after haploidentical hematopoietic stem cell transplantation.
Exp Hematol Oncol
; 11(1): 25, 2022 May 03.
Artigo
Inglês
| MEDLINE | ID: mdl-35505384
9.
Meta-Analysis of Interleukin-2 Receptor Antagonists as the Treatment for Steroid-Refractory Acute Graft-Versus-Host Disease.
Front Immunol
; 12: 749266, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34621279
10.
Preemptive Immunotherapy for Minimal Residual Disease in Patients With t(8;21) Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation.
Front Oncol
; 11: 773394, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-35070977